DocGo Inc. (NASDAQ:DCGO) Given Consensus Recommendation of “Hold” by Analysts

DocGo Inc. (NASDAQ:DCGOGet Free Report) has received a consensus rating of “Hold” from the six brokerages that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $2.3750.

A number of research analysts have recently commented on DCGO shares. Wall Street Zen upgraded shares of DocGo from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Needham & Company LLC restated a “buy” rating and issued a $3.00 price target on shares of DocGo in a report on Tuesday, March 17th. Canaccord Genuity Group lowered their price objective on shares of DocGo from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 25th. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Finally, Stifel Nicolaus reduced their target price on shares of DocGo from $4.00 to $2.50 and set a “buy” rating on the stock in a research report on Tuesday, March 17th.

Read Our Latest Analysis on DCGO

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Boothbay Fund Management LLC raised its position in DocGo by 39.0% during the 4th quarter. Boothbay Fund Management LLC now owns 200,947 shares of the company’s stock valued at $176,000 after purchasing an additional 56,413 shares in the last quarter. Oxford Asset Management LLP grew its position in shares of DocGo by 122.6% during the 2nd quarter. Oxford Asset Management LLP now owns 93,126 shares of the company’s stock worth $146,000 after buying an additional 51,298 shares in the last quarter. Empowered Funds LLC grew its position in shares of DocGo by 14.6% during the 4th quarter. Empowered Funds LLC now owns 138,306 shares of the company’s stock worth $121,000 after buying an additional 17,607 shares in the last quarter. BNP Paribas Financial Markets increased its stake in shares of DocGo by 411.3% during the third quarter. BNP Paribas Financial Markets now owns 81,482 shares of the company’s stock valued at $111,000 after buying an additional 65,545 shares during the period. Finally, Wells Fargo & Company MN raised its holdings in shares of DocGo by 44.3% in the fourth quarter. Wells Fargo & Company MN now owns 100,811 shares of the company’s stock valued at $88,000 after acquiring an additional 30,957 shares in the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Stock Down 2.4%

NASDAQ DCGO opened at $0.57 on Thursday. The company has a fifty day moving average of $0.61 and a two-hundred day moving average of $0.73. The firm has a market capitalization of $55.91 million, a price-to-earnings ratio of -0.30 and a beta of 1.00. DocGo has a 52 week low of $0.49 and a 52 week high of $1.78.

DocGo (NASDAQ:DCGOGet Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.10). The firm had revenue of $75.55 million for the quarter, compared to analysts’ expectations of $72.48 million. DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%. Equities research analysts anticipate that DocGo will post -0.12 EPS for the current year.

About DocGo

(Get Free Report)

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.

Featured Stories

Analyst Recommendations for DocGo (NASDAQ:DCGO)

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.